Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening subjects with RDEB to evaluate characteristics of the subjects and their cells in order to develop new strategies of therapy and determine whether subjects could be candidates for treatment studies.
- Clinical diagnosis of RDEB by local dermatologist
- 7 years of age or older
- Visit clinicaltrials.gov for exclusion criteria.
If you have any questions or are interested in participating in this clinical trial, please contact:
- Phone: (650) 721-7149
- Email: firstname.lastname@example.org
Stanford University School of Medicine
Stanford, California, United States, 9430